title: The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions).
abstract: 2013 was the year of transcatheter heart valve interventions. Not least because of the 2012 European guidelines on the management of valvular heart disease (VHD), the multidisciplinary heart team approach became an established concept. Decision-making, when a patient is too 'sick' for surgery and too 'healthy' for catheter-based interventions, is complex, since VHD is often seen at an older age and, as a consequence, there is a higher frequency of co-morbidity and frailty. However, before TAVI and other transcatheter heart valve interventions can be expanded to intermediate-risk patients, evidence in favour of this less invasive treatment has to be provided by upcoming randomized clinical trials.
authors.affiliation: Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany.
authors.forename: Eberhard
authors.initials: E
authors.lastname: Grube
authors.forename: Jan-Malte
authors.initials: JM
authors.lastname: Sinning
authors.forename: Alec
authors.initials: A
authors.lastname: Vahanian
mesh_terms: D006328:Cardiac Catheterization / Q000639:trends*; D002309:Cardiology / Q000639:trends*; D005544:Forecasting; D006349:Heart Valve Diseases / Q000628:therapy*; D006350:Heart Valve Prosthesis / Q000639:trends; D019918:Heart Valve Prosthesis Implantation / Q000639:trends; D006801:Humans
keywords: Annular rupture; Anticoagulation; Aortic regurgitation; Aortic stenosis; Boston Lotus Valve; Co-morbidities; CoreValve; Direct Flow Medical Valve; Durability; Edwards-SAPIEN; Frailty; GARY; Intermediate risk; MitraClip; Mitral regurgitation; Mitral stenosis; NOAC; New oral anticoagulants; Outcome; PMC; Paravalvular aortic regurgitation; Paravalvular leakage; Risk; Stroke; TAVI; TAVR; TMVR; VIV; Valve-in-valve; Valvular heart disease